Law360, New York (January 23, 2012, 6:55 PM EST) -- Ropes & Gray LLP earned a spot on Law360's list of Health Groups of 2011 not because of its work in the courtroom, but in the boardroom, helping to broker a trio of billion-dollar transactions, topped by biotechnology company Genzyme Corp.'s $20.1 billion sale to French pharmaceutical giant Sanofi-Aventis SA.
The transaction, which closed in April, was one beset with shareholder lawsuits and accusations that Sanofi was undervaluing Genzyme. Ropes & Gray partner Marc Rubenstein, who co-chairs the firm's life sciences practice, says the ability of its life science and health lawyers to tackle all aspects of the deal — securities...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!